Literature DB >> 31285626

Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer.

Lei Wang1, Diana L Simons1, Xuyang Lu2, Travis Y Tu1, Shawn Solomon1, Roger Wang1, Anthony Rosario1, Christian Avalos1, Daniel Schmolze3, John Yim4, James Waisman5, Peter P Lee6.   

Abstract

Regulatory T (Treg) cells play a major role in the development of an immunosuppressive tumor microenvironment. The origin of intratumoral Treg cells and their relationship with peripheral blood Treg cells remain unclear. Treg cells consist of at least three functionally distinct subpopulations. Here we show that peripheral blood CD45RA-FOXP3hi Treg cells (Treg II cells) are phenotypically closest to intratumoral Treg cells, including in their expression of CCR8. Analyses of T cell antigen receptor repertoires further support the hypothesis that intratumoral Treg cells may originate primarily from peripheral blood Treg II cells. Moreover, the signaling responsiveness of peripheral blood Treg II cells to immunosuppressive, T helper type 1 (TH1) and T helper type 2 (TH2) cytokines reflects intratumoral immunosuppressive potential, and predicts future relapse in two independent cohorts of patients with breast cancer. Together, our findings give important insights into the relationship between peripheral blood Treg cells and intratumoral Treg cells, and highlight cytokine signaling responsiveness as a key determinant of intratumoral immunosuppressive potential and clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31285626      PMCID: PMC8802768          DOI: 10.1038/s41590-019-0429-7

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  48 in total

1.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

Authors:  Andrea Facciabene; Xiaohui Peng; Ian S Hagemann; Klara Balint; Andrea Barchetti; Li-Ping Wang; Phyllis A Gimotty; C Blake Gilks; Priti Lal; Lin Zhang; George Coukos
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

2.  Transforming Growth Factor-β Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses.

Authors:  Joanne E Konkel; Dunfang Zhang; Peter Zanvit; Cheryl Chia; Tamsin Zangarle-Murray; Wenwen Jin; Songlin Wang; WanJun Chen
Journal:  Immunity       Date:  2017-04-18       Impact factor: 31.745

Review 3.  The regulation of immune tolerance by FOXP3.

Authors:  Ling Lu; Joseph Barbi; Fan Pan
Journal:  Nat Rev Immunol       Date:  2017-07-31       Impact factor: 53.106

Review 4.  FOXP3+ regulatory T cells in the human immune system.

Authors:  Shimon Sakaguchi; Makoto Miyara; Cristina M Costantino; David A Hafler
Journal:  Nat Rev Immunol       Date:  2010-06-18       Impact factor: 53.106

Review 5.  Regulatory T cells: mechanisms of differentiation and function.

Authors:  Steven Z Josefowicz; Li-Fan Lu; Alexander Y Rudensky
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

6.  OX40 costimulation turns off Foxp3+ Tregs.

Authors:  Minh Diem Vu; Xiang Xiao; Wenda Gao; Nicolas Degauque; Ming Chen; Alexander Kroemer; Nigel Killeen; Naoto Ishii; Xian Chang Li
Journal:  Blood       Date:  2007-06-15       Impact factor: 22.113

Review 7.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

8.  Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer.

Authors:  George Plitas; Catherine Konopacki; Kenmin Wu; Paula D Bos; Monica Morrow; Ekaterina V Putintseva; Dmitriy M Chudakov; Alexander Y Rudensky
Journal:  Immunity       Date:  2016-11-15       Impact factor: 31.745

9.  Natural and induced T regulatory cells in cancer.

Authors:  Dennis O Adeegbe; Hiroyoshi Nishikawa
Journal:  Front Immunol       Date:  2013-07-11       Impact factor: 7.561

10.  The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder.

Authors:  Alexander S Baras; Charles Drake; Jen-Jane Liu; Nilay Gandhi; Max Kates; Mohamed O Hoque; Alan Meeker; Noah Hahn; Janis M Taube; Mark P Schoenberg; George Netto; Trinity J Bivalacqua
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

View more
  42 in total

1.  Identification of molecular heterogeneity of hepatocellular carcinoma based on immune gene expression signatures.

Authors:  Xin Lou; Juan-Juan Wang; Ya-Qing Wei; Ying-Jie He; Zhi-Jia Jiang; Jin-Jin Sun
Journal:  Med Oncol       Date:  2021-03-31       Impact factor: 3.064

2.  Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells.

Authors:  Michael Delacher; Malte Simon; Lieke Sanderink; Agnes Hotz-Wagenblatt; Marina Wuttke; Kathrin Schambeck; Lisa Schmidleithner; Sebastian Bittner; Asmita Pant; Uwe Ritter; Thomas Hehlgans; Dania Riegel; Verena Schneider; Florian Kai Groeber-Becker; Andreas Eigenberger; Claudia Gebhard; Nicholas Strieder; Alexander Fischer; Michael Rehli; Petra Hoffmann; Matthias Edinger; Till Strowig; Jochen Huehn; Christian Schmidl; Jens M Werner; Lukas Prantl; Benedikt Brors; Charles D Imbusch; Markus Feuerer
Journal:  Immunity       Date:  2021-03-30       Impact factor: 31.745

3.  CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.

Authors:  Tao Wang; Quan Zhou; Han Zeng; Hongyu Zhang; Zhaopei Liu; Jialiang Shao; Zewei Wang; Ying Xiong; Jiajun Wang; Qi Bai; Yu Xia; Yiwei Wang; Li Liu; Yu Zhu; Le Xu; Bo Dai; Jianming Guo; Yuan Chang; Xiang Wang; Jiejie Xu
Journal:  Cancer Immunol Immunother       Date:  2020-05-04       Impact factor: 6.968

4.  Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot.

Authors:  Zhaoting Li; Lianghan Zhu; Honghao Sun; Yuexin Shen; Dandan Hu; Wenhao Wu; Yixin Wang; Chenggen Qian; Minjie Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-14       Impact factor: 11.205

5.  A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy.

Authors:  Wonmo Sung; Clemens Grassberger; Aimee Louise McNamara; Lucas Basler; Stefanie Ehrbar; Stephanie Tanadini-Lang; Theodore S Hong; Harald Paganetti
Journal:  Radiother Oncol       Date:  2020-07-15       Impact factor: 6.280

6.  Peripheral Circulating CD45RA-FOXP3hi T Regulatory (TReg) II Cells Provide a Window into the Activity of Intratumoral TReg Cells.

Authors:  Sara I Pai; Francesco M Marincola
Journal:  Trends Cancer       Date:  2019-12-03

Review 7.  Chemokines and the immune response to cancer.

Authors:  Aleksandra J Ozga; Melvyn T Chow; Andrew D Luster
Journal:  Immunity       Date:  2021-04-10       Impact factor: 31.745

8.  Systemic dysfunction and plasticity of the immune macroenvironment in cancer models.

Authors:  Breanna M Allen; Kamir J Hiam; Cassandra E Burnett; Anthony Venida; Rachel DeBarge; Iliana Tenvooren; Diana M Marquez; Nam Woo Cho; Yaron Carmi; Matthew H Spitzer
Journal:  Nat Med       Date:  2020-05-25       Impact factor: 53.440

9.  Human regulatory T cells (Treg) and their response to cancer.

Authors:  Theresa L Whiteside
Journal:  Expert Rev Precis Med Drug Dev       Date:  2019-07-15

10.  Transcriptomic and Immunophenotypic Characterization of Tumor Immune Microenvironment in Squamous Cell Carcinoma of the Oral Tongue.

Authors:  Kyriakos Chatzopoulos; Sotiris Sotiriou; Andrea R Collins; Panagiotis Kartsidis; Alessandra C Schmitt; Xianfeng Chen; Khashayarsha Khazaie; Michael L Hinni; Colleen A Ramsower; Matthew A Zarka; Samir H Patel; Joaquin J Garcia
Journal:  Head Neck Pathol       Date:  2020-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.